Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
23.80
+0.76 (3.30%)
Dec 20, 2024, 4:00 PM EST - Market closed
Dianthus Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 704 | 154 | - | - |
| Enterprise Value | 424 | -35 | - | - |
| Last Close Price | 23.80 | 10.40 | - | - |
| PS Ratio | 125.04 | 54.53 | - | - |
| PB Ratio | 2.07 | 0.91 | - | - |
| P/TBV Ratio | 2.38 | 0.91 | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | - |
| Asset Turnover | 0.02 | 0.02 | 0.14 | - |
| Quick Ratio | 18.07 | 18.09 | 9.86 | 1.70 |
| Current Ratio | 18.30 | 18.42 | 9.97 | 1.75 |
| Return on Equity (ROE) | -25.99% | -35.92% | -73.25% | - |
| Return on Assets (ROA) | -18.96% | -22.94% | -40.12% | - |
| Return on Capital (ROIC) | -20.03% | -24.69% | -47.27% | - |
| Earnings Yield | -9.52% | -28.26% | - | - |
| FCF Yield | -8.90% | -23.99% | - | - |
| Buyback Yield / Dilution | -1617.89% | -489.48% | 78.18% | - |
| Total Shareholder Return | -1617.89% | -489.48% | 78.18% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.